Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00226629 |
Recruitment Status :
Completed
First Posted : September 27, 2005
Last Update Posted : August 25, 2017
|
Sponsor:
Lawson Health Research Institute
Information provided by (Responsible Party):
Lawson Health Research Institute
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | September 23, 2005 | ||||
First Posted Date ICMJE | September 27, 2005 | ||||
Last Update Posted Date | August 25, 2017 | ||||
Actual Study Start Date ICMJE | August 2003 | ||||
Actual Primary Completion Date | June 2006 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE | Not Provided | ||||
Original Primary Outcome Measures ICMJE | Not Provided | ||||
Change History | |||||
Current Secondary Outcome Measures ICMJE | Not Provided | ||||
Original Secondary Outcome Measures ICMJE | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC | ||||
Official Title ICMJE | Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC | ||||
Brief Summary | The purpose of this study is to compare the cost effectiveness, quality of life and outcomes of the endovascular stent graft repair with the open surgical repair of abdominal aortic aneurysms. | ||||
Detailed Description | Abdominal Aortic Aneurysms have been traditionally repaired using the standard open surgical technique. The use of Endovascular stent grafts(EVAR) to treat aortic aneurysms has been ongoing for approximately 8-10 years. Use of EVAR to treat aortic aneurysms in high risk has been reported to be beneficial. However, the costs of this therapy are quite significant and therefore in order to best understand the cost effectiveness of this type of aneurysm treatment, an extensive prospective comparative evaluation is required. This study will compare outcomes and cost-effectiveness for patients receiving EVAR, with high surgical risk, and OSR, with low surgical risk, and OSR, where there is high surgical risk and not suitable for EVAR based on anatomical complexity. Demographic, medical, health care resource utilization, cost, and quality of life information is collected from participating patients over a period of a year following repair. | ||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment |
||||
Condition ICMJE | Abdominal Aortic Aneurysm | ||||
Intervention ICMJE | Procedure: Endovascular vs Open Repair | ||||
Study Arms ICMJE | Not Provided | ||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Enrollment ICMJE |
130 | ||||
Original Enrollment ICMJE | Same as current | ||||
Actual Study Completion Date ICMJE | August 2007 | ||||
Actual Primary Completion Date | June 2006 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 40 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | No | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | Not Provided | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT00226629 | ||||
Other Study ID Numbers ICMJE | R-03-155 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE | Not Provided | ||||
Responsible Party | Lawson Health Research Institute | ||||
Study Sponsor ICMJE | Lawson Health Research Institute | ||||
Collaborators ICMJE | Not Provided | ||||
Investigators ICMJE |
|
||||
PRS Account | Lawson Health Research Institute | ||||
Verification Date | August 2017 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |